EP2103724B1 - Wiping cloth with an antibacterial non-woven fabric - Google Patents
Wiping cloth with an antibacterial non-woven fabric Download PDFInfo
- Publication number
- EP2103724B1 EP2103724B1 EP08005131A EP08005131A EP2103724B1 EP 2103724 B1 EP2103724 B1 EP 2103724B1 EP 08005131 A EP08005131 A EP 08005131A EP 08005131 A EP08005131 A EP 08005131A EP 2103724 B1 EP2103724 B1 EP 2103724B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dopant
- component
- use according
- fiber
- bicomponent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004744 fabric Substances 0.000 title claims 7
- 239000004745 nonwoven fabric Substances 0.000 title abstract description 27
- 230000000844 anti-bacterial effect Effects 0.000 title description 2
- 239000000835 fiber Substances 0.000 claims abstract description 55
- 239000002019 doping agent Substances 0.000 claims abstract description 38
- -1 polyethylene Polymers 0.000 claims abstract description 26
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229910052709 silver Inorganic materials 0.000 claims abstract description 21
- 229920000139 polyethylene terephthalate Polymers 0.000 claims abstract description 20
- 239000005020 polyethylene terephthalate Substances 0.000 claims abstract description 20
- 239000004332 silver Substances 0.000 claims abstract description 19
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 18
- 229920000728 polyester Polymers 0.000 claims abstract description 9
- 239000004952 Polyamide Substances 0.000 claims abstract description 6
- 229920002647 polyamide Polymers 0.000 claims abstract description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000004698 Polyethylene Substances 0.000 claims abstract description 4
- 229910052802 copper Inorganic materials 0.000 claims abstract description 4
- 239000010949 copper Substances 0.000 claims abstract description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052737 gold Inorganic materials 0.000 claims abstract description 4
- 239000010931 gold Substances 0.000 claims abstract description 4
- 229920000573 polyethylene Polymers 0.000 claims abstract description 4
- 238000009826 distribution Methods 0.000 claims description 3
- 230000007704 transition Effects 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract 2
- 238000009835 boiling Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 description 13
- 239000004594 Masterbatch (MB) Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 229920002292 Nylon 6 Polymers 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000003632 microfilament Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000007748 combinatorial effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/005—Synthetic yarns or filaments
- D04H3/009—Condensation or reaction polymers
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47L—DOMESTIC WASHING OR CLEANING; SUCTION CLEANERS IN GENERAL
- A47L13/00—Implements for cleaning floors, carpets, furniture, walls, or wall coverings
- A47L13/10—Scrubbing; Scouring; Cleaning; Polishing
- A47L13/16—Cloths; Pads; Sponges
- A47L13/17—Cloths; Pads; Sponges containing cleaning agents
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
- D01F1/103—Agents inhibiting growth of microorganisms
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/14—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one polyester as constituent
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/005—Synthetic yarns or filaments
- D04H3/007—Addition polymers
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/005—Synthetic yarns or filaments
- D04H3/009—Condensation or reaction polymers
- D04H3/011—Polyesters
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/016—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the fineness
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/08—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of strengthening or consolidating
- D04H3/14—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of strengthening or consolidating with bonds between thermoplastic yarns or filaments produced by welding
- D04H3/147—Composite yarns or filaments
Definitions
- the invention relates to a use according to the preamble of patent claim 1.
- Nonwovens with antimicrobial finish are from the US 2004/0214485 A1 and the WO 2007/078203 A1 known.
- nonwovens which have an antimicrobial dopant.
- an antimicrobial substance acts antibacterial, antiviral, antifungal and / or against spores.
- silver in particular has proven to be a suitable antimicrobial agent.
- silver is also determined by means of binders on textile materials. By washing processes, however, the applied silver is peeled off and can penetrate into water treatment plants. This is a very detrimental effect associated with high economic damage.
- the invention is therefore based on the object to provide a wipe, which is characterized by a long-term effective reactivity of the antimicrobial dopant and at the same time is multi-cost washable.
- a nonwoven fabric which has continuous fibers has a good quality even after several washing processes. This is due to the fact that Endlosfasem are entangled at a variety of locations with each other and therefore difficult to detach from the nonwoven composite.
- the use of bicomponent fibers with a fibrous body in which at least one dopant is included for antimicrobial finishing allows the nonwoven to be consolidated. It is concretely conceivable to solidify the nonwoven fabric by a water jet needling process. The bicomponent fibers can be partially or completely split up into very fine elementary fibers. It is also conceivable to solidify the nonwoven fabric by a thermal treatment.
- the antimicrobial dopant into the fiber body ensures extremely long term delivery of the dopant.
- the antimicrobial effect is limited to the wipe by largely preventing germ growth in the wipe itself.
- the antimicrobial active substance is not released to a considerable extent on surfaces which are treated with the wipe.
- the dopant is incorporated directly into the fiber body, which creates an antimicrobial effect, especially on the surface of the endless fibers. The release of the dopant takes place only in very small amounts, it remains largely bound in the nonwoven fabric or in the fiber body.
- a washable, permanently antimicrobially-doped wipe for example, does not allow any bacterial decomposition in milk-contaminated state, so that almost no odor pollution in the household can arise.
- Very particularly advantageous is the use in commercial cleaning, since wipers are washed and dried here daily. If the wipes according to the invention equipped antimicrobial, it can be dispensed with a subsequent drying of the wipes. Experiments have shown that with each wash an energy saving of more than 3 kWh / kg wipe can be realized.
- the bicomponent fibers are at least partially split into endless elementary fibers.
- a nonwoven fabric with very fine elementary fibers can be created.
- the splitting can take place, for example, by means of a water-jet needling method, wherein the elementary fibers are additionally entwined with each other. This allows the Nonwoven fabric are solidified.
- the elementary fibers provide a larger surface area than the unsplit bicomponent fibers with a constant basis weight of the nonwoven fabric. Through the surface, the dopant can interact to the outside,
- the bicomponent fiber is designed as a PIE fiber.
- a relatively coarse bicomponent fiber can be split into very fine Etementarmaschinen with cake piece-like or circular segment-like cross-sections.
- Etementarmaschinen cake piece-like or circular segment-like cross-sections.
- the nonwoven fabric has a color. Surprisingly, it has been found that an antimicrobially finished nonwoven fabric can be dyed and yet retains its antimicrobial effect
- the elementary fibers can be designed particularly advantageously as microfilaments of a fineness of 0.05 to 1 dtex. Microfilaments of such fineness provide a particularly large contact surface for bacteria and spores.
- the dopant could be homogeneously distributed only in one component of the fiber body.
- side-by-side bicomponent endless fibers are also used. It is also conceivable to use Iceland-in-the-Sea bicomponent fiber end-products.
- the dopant could be present in a concentration of at least 200 ppm in the nonwoven fabric. Surprisingly, it has been found that even such a low concentration of the dopant can develop an antimicrobial action against viruses, spores or bacteria.
- the dopant could be present in a concentration of at most 500 ppm in the nonwoven fabric.
- the choice of this concentration has been found to be advantageous to give a dyed nonwoven durable reactivity.
- the doping is shielded by the coloring, it can still exert its effect to a sufficient extent by the said concentration.
- the bicomponent fiber could be a component of polyamide or polyethylene and a component of polyethylene terephthalate or polyester
- the bicomponent fiber could comprise 30% polyamide or polymethylene.
- the proportion of polyethylene terephthalate or polyester is essentially 70%.
- the dopant could be homogeneously distributed in the component of the fiber body comprising polyethylene terephthalate or polyester.
- Polyethylene terephthalate and polyesters have proven to be particularly suitable media for receiving the dopant. Due to the higher mass fraction of the component comprising polyethylene terephthalate or polyester, a more effective volume distribution of the dopant in the nonwoven fabric can be achieved.
- the dopant could be configured as an element of a subgroup, in particular subgroup 1b of the Periodic Table of the Elements.
- Subgroup elements are characterized by antimicrobial activity. Against this background, it is conceivable that several subgroup elements are present together in the fiber body in order to selectively counteract different bacterial species. It has been shown in test series that there is a ranking of the substances used in terms of antimicrobial effectiveness. This can be represented as follows. Silver is the most effective substance, followed by mercury, copper, cadmium, chromium, blel, cobalt, gold, Zinc, iron and finally manganese. The same applies to salts and complexes of the named elements or substances.
- the dopant could be designed against this background as silver, gold or copper. These elements show a particularly reliable antimicrobial effect and are readily available commercially as fine particles.
- the nonwoven fabric could have a basis weight of at least 20 g / m 2 . This basis weight has proved to be particularly advantageous for producing wipes.
- the nonwoven fabric described here can easily be in contact with human skin.
- the nonwoven fabric described herein has such a low concentration of a dopant that the human skin is not irritated.
- eczema patients require a gentle nonwoven fabric, as described here.
- the continuous fibers also show a sufficient concentration of the dopant on the filament surface in order to kill bacteria, viruses and spores.
- Fig. 1 a nonwoven fabric with bicomponent fibers, which are designed as continuous fibers.
- the bicomponent fibers are configured as PIE fibers and consist of 30% polyamide 6 and about 70% Polyethytentereptaht.
- the polyethylene terephthalate is enriched with the dopant silver.
- the dopant silver is homogeneously distributed in the component of the fiber body having polyethylene terephthalate.
- the silver is present in a concentration of at least 200 ppm and at most 500 ppm.
- Fig. 2 shows the bicomponent fibers according to Fig. 1 which have eight segments of polyethylene terephthalate.
- the segments have the dopant Silver on.
- the silver can be recognized in the form of bright spots in the scanning electron micrograph.
- the table shows the three embodiments 1 to 3 of the nonwoven fabric according to the invention.
- Embodiments 1 to 3 show different concentrations of the dopant in the polyethylene terephthalate component.
- the production of nonwovens was carried out in accordance with the in DE 697 25 051 T2 described method and analogous to the preparation of the comparative sample EVOLON 130 g / m 2 or EVO 130th
- the polyethylene terephthalate component was prepared in each of Embodiments 1 to 3 in the following manner.
- Embodiment 1 970 g of polyethylene terephthalate were mixed with 30 g of a master batch component to obtain a 3% concentration of master batch as shown in the table.
- the masterbatch component contained 99% polyethylene terephthalate and 1% silver.
- two 960 grams of polyethylene terephthalate were mixed with 40 grams of the master batch component.
- 950 g of polyethylene terephthalate were mixed with 50 g of said master batch component.
- the dopant used was silver from Silanotex GmbH, 80687 Kunststoff.
- the master batch was "Nano-Silver-Master-Batch" of the named company in the mentioned quantities.
- the nonwoven fabrics of Working Examples 1 to 3 were evaluated for their tear propagation resistance, tear resistance, extensibility, uniformity, permeability, thickness, basis weight and shrinkage.
- N stands for Newton
- MD machine direction (production direction)
- CD cross direction. Denote MD and CD while orthogonal to each other load directions, namely in the direction of production and orthogonal thereto.
- the comparative sample used was a nonwoven fabric of the type Evolon with a basis weight of 130 g / m 2 .
- the comparative example is made from bicomponent fibers comprising 70% polyethylene terephthalate and 30% polyamide 6.
- the polyamide used in the embodiments 1 to 3 is also polyamide 6.
- the table essentially states that the doping of embodiments 1 to 3 with silver has no negative effects on the mechanical properties of the exemplary embodiments in comparison with the comparative sample.
- the exemplary embodiments were manufactured analogously to the comparative sample except for the doping, which is commercially available under the product designation "EVOLON 130 g / m 2 " or "EVO 130".
- table 1 2 3 comparison sample 130g / m 2 130g / m 2 130g / m 2 EVO 130g / m 2 standard % Master Batch PET 3%; 4% 5% - Width (mm 2050 2050 2050 2050 Belt speed (m / min) 11.3 11.3 11.3 11.3 11.3 Basis weight (g / m 2 ) 125 126 127 129 Tear strength before washing (N) MD 9.4 10.6 9.8 9.6 CD 9.6 9.4 9.7 9.4 Tear resistance before washing (N) MD 349 360 368 393 CD 400 404 394 415 Extensibility before washing (%) MD 42 41 45 43 CD 48 45 49 48 Thickness (mm) 0.46 0.47 0.47 12:46 Unity CV -% 6.1 5.9 6.4 5.8 Permeability before washing in Vm 2 / s at 100 bar 45 44 47 45 Tear resistance after
Abstract
Description
Die Erfindung betrifft eine Verwendung gemäß dem Oberbegriff des Patentanspruchs 1.The invention relates to a use according to the preamble of patent claim 1.
Vliesstoffe mit antimikrobieller Ausrüstung sind aus der
Aus dem Stand der Technik sind Vliesstoffe bekannt, weiche einen antimikrobiell wirkenden Dotierstoff aufweisen. Dabei wirkt ein antimikrobiell wirkender Stoff antibakteriell, antiviral, antimykotisch und/ oder gegen Sporen. Vor diesem Hintergrund hat sich insbesondere Silber als geeigneter antimikrobieller Stoff erwiesen.From the prior art nonwovens are known which have an antimicrobial dopant. In this case, an antimicrobial substance acts antibacterial, antiviral, antifungal and / or against spores. Against this background, silver in particular has proven to be a suitable antimicrobial agent.
Es ist bereits bekannt, Toilettenpapier mit Silber auszurüsten. Diese Ausrüstung ist jedoch nicht dauerhaft, da das Silber lediglich oberflächlich auf das Toilettenpapier aufgetragen wird.It is already known to equip toilet paper with silver. However, this equipment is not durable, as the silver is only superficially applied to the toilet paper.
Häufig wird Silber auch mittels Bindemitteln an textilen Stoffen festgelegt. Durch Waschprozesse wird das aufgetragene Silber jedoch abgelöst und kann in Wasseraufbereitungsanlagen eindringen. Dies ist ein äußerst nachteiliger Effekt, mit dem hohe wirtschaftliche Schäden verbunden sind.Frequently, silver is also determined by means of binders on textile materials. By washing processes, however, the applied silver is peeled off and can penetrate into water treatment plants. This is a very detrimental effect associated with high economic damage.
Der Erfindung liegt daher die Aufgabe zu Grunde, ein Wischtuch anzugeben, welches sich durch eine langfristig wirksame Reaktivität des antimikrobiell wirkenden Dotierstoffes auszeichnet und zugleich mehrfach kostengünstig waschbar ist.The invention is therefore based on the object to provide a wipe, which is characterized by a long-term effective reactivity of the antimicrobial dopant and at the same time is multi-cost washable.
Erfindungsgemäß wird die voranstehende Aufgabe mit den Merkmalen des Patentanspruchs 1 gelöst.According to the invention the above object is achieved with the features of claim 1.
Erfindungsgemäß ist zunächst erkannt worden, dass ein Vliesstoff, welcher Endlosfasem aufweist, auch nach mehreren Waschprozessen eine gute Qualität aufweist. Dies hängt damit zusammen, dass Endlosfasem an einer Vielzahl von Stellen miteinander verschlungen sind und sich daher nur schwer aus dem Vliesstoffverbund herauslösen können. Des Weiteren ist erkannt worden, dass die Verwendung von Bikomponentenfasern mit einem Faserkörper, in welchem zumindest ein Dotierstoff zur antimikrobiellen Ausrüstung aufgenommen ist, erlaubt, den Vliesstoff zu verfestigen. Dabei ist konkret denkbar den Vliesstoff durch einen Wasserstrahlvemadelungsprozess zu verfestigen. Dabei können die Bikomponentenfasern teilweise oder vollständig zu sehr feinen Elementarfasern aufgesplittet werden. Denkbar ist auch, den Vliesstoff durch eine thermische Behandlung zu verfestigen. Ganz konkret ist erkannt worden, dass die Einbindung des antimikrobiellen Dotierstoffes in den Faserkörper eine äußerst langfristige Abgabe des Dotierstoffes sicherstellt. Die antimikrobielle Wirkung wird auf das Wischtuch begrenzt, indem Keimwachstum im Wischtuch selbst weitgehend verhindert wird. Erfindungsgemäß wird der antimikrobiell wirksame Stoff gerade nicht in erheblichem Maße an Oberflächen abgegeben, die mit dem Wischtuch behandelt werden. Der Dotierstoff wird direkt in den Faserkörper eingebunden, wodurch vor allem an der Oberfläche der Endlosfasem eine antimikrobielle Wirkung entsteht. Die Freisetzung des Dotierstoffes erfolgt nur in sehr geringen Mengen, er bleibt weitestgehend im Vliesstoff bzw. im Faserkörper gebunden.According to the invention, it has first been recognized that a nonwoven fabric which has continuous fibers has a good quality even after several washing processes. This is due to the fact that Endlosfasem are entangled at a variety of locations with each other and therefore difficult to detach from the nonwoven composite. Furthermore, it has been recognized that the use of bicomponent fibers with a fibrous body in which at least one dopant is included for antimicrobial finishing allows the nonwoven to be consolidated. It is concretely conceivable to solidify the nonwoven fabric by a water jet needling process. The bicomponent fibers can be partially or completely split up into very fine elementary fibers. It is also conceivable to solidify the nonwoven fabric by a thermal treatment. All Specifically, it has been recognized that incorporation of the antimicrobial dopant into the fiber body ensures extremely long term delivery of the dopant. The antimicrobial effect is limited to the wipe by largely preventing germ growth in the wipe itself. According to the invention, the antimicrobial active substance is not released to a considerable extent on surfaces which are treated with the wipe. The dopant is incorporated directly into the fiber body, which creates an antimicrobial effect, especially on the surface of the endless fibers. The release of the dopant takes place only in very small amounts, it remains largely bound in the nonwoven fabric or in the fiber body.
Die erfindungsgemäße Verwendung zeigt überraschenderweise einen kombinatorischen Effekt, der sich einer hohen Reaktivität des Dotierstoffes und einer hohen Waschbeständigkeit des Wischtuches niederschlägt. Ein waschbares, dauerhaft antimikrobiell dotiertes Wischtuch lässt beispielsweise in milchkontaminiertem Zustand keine bakterielle Zersetzung zu, so dass nahezu keine Geruchsbelastung im Haushalt entstehen kann. Ganz besonders vorteilhaft ist jedoch die Benutzung in der gewerblichen Reinigung, da hier Wischtücher täglich gewaschen und getrocknet werden. Werden die Wischtücher erfindungsgemäß antimikrobiell ausgerüstet, so kann auf eine anschließende Trocknung der Wischtücher verzichtet werden. Versuche haben gezeigt, dass bei jeder Wäsche eine Energieeinsparung von mehr als 3 kWh/kg Wischtuch realisiert werden kann.The use according to the invention surprisingly shows a combinatorial effect, which is reflected in a high reactivity of the dopant and a high washing resistance of the wipe. A washable, permanently antimicrobially-doped wipe, for example, does not allow any bacterial decomposition in milk-contaminated state, so that almost no odor pollution in the household can arise. Very particularly advantageous, however, is the use in commercial cleaning, since wipers are washed and dried here daily. If the wipes according to the invention equipped antimicrobial, it can be dispensed with a subsequent drying of the wipes. Experiments have shown that with each wash an energy saving of more than 3 kWh / kg wipe can be realized.
Die Bikomponentenfasern sind zumindest teilweise in endlose Elementarfasern aufgespaltet Durch diese konkrete Ausgestaltung kann ein Vliesstoff mit sehr feinen Elementarfasern geschaffen werden. Die Aufspaltung kann beispielsweise mittels eines Wasserstrahlvernadelungsverfahrens erfolgen, wobei die Elementarfasern noch zusätzlich untereinander verschlungen werden. Hierdurch kann der Vliesstoff verfestigt werden. Dabei ist vorteilhaft, dass die Elementarfasern eine größere Oberfläche als die ungesplitteten Bikomponentenfasern bei gleichbleibendem Flächengewicht des Vliesstoffs bieten. Durch die Oberfläche kann der Dotierstoff nach außen in Wechselwirkung treten,The bicomponent fibers are at least partially split into endless elementary fibers. By this specific embodiment, a nonwoven fabric with very fine elementary fibers can be created. The splitting can take place, for example, by means of a water-jet needling method, wherein the elementary fibers are additionally entwined with each other. This allows the Nonwoven fabric are solidified. It is advantageous that the elementary fibers provide a larger surface area than the unsplit bicomponent fibers with a constant basis weight of the nonwoven fabric. Through the surface, the dopant can interact to the outside,
Die Bikomponentenfaser ist als PIE-Faser ausgestaltet. Durch diese konkrete Ausgestaltung kann eine relativ grobe Bikomponentenfaser in sehr feine Etementarfasern mit kuchenstückartigen bzw. kreissegmentartigen Querschnitten aufgespalten werden. Lediglich beispielhaft sei an dieser Stelle auf die
Der Vliesstoff weist eine Färbung auf. Überraschend wurde festgestellt, dass ein antimikrobiell ausgerüsteter Vliesstoff eingefärbt werden kann und dennoch seine antimikrobielle Wirkung beibehältThe nonwoven fabric has a color. Surprisingly, it has been found that an antimicrobially finished nonwoven fabric can be dyed and yet retains its antimicrobial effect
Folglich ist die genannte Aufgabe gelöst.Consequently, the stated object is achieved.
Besonders vorteilhaft können die Elementarfasern als Mikrofilamente einer Feinheit von 0,05 bis 1 dtex ausgestaltet sein. Mikrofilamente einer solchen Feinheit stellen eine besonders große Kontaktoberfläche für Bakterien und Sporen zur Verfügung.The elementary fibers can be designed particularly advantageously as microfilaments of a fineness of 0.05 to 1 dtex. Microfilaments of such fineness provide a particularly large contact surface for bacteria and spores.
Der Dotierstoff könnte nur in einer Komponente des Faserkörpers homogen verteilt sein. Durch diese konkrete Ausgestaltung kann beispielsweise der Mantel einer Kem-Mantel-Endlosfaser aufgeschmolzen werden, um sich mit weiteren Endlosfasern zu verbinden, ohne dass der im Kem vorliegende Dotierstoff negativ beeinträchtigt wird. Vor diesem Hintergrund ist denkbar, dass auch Side-by-Side-Bikomponentenendlosfasern verwendet werden. Des Weiteren ist denkbar, Island-in-the-Sea-Bikomponentenendliosfasern zu verwenden.The dopant could be homogeneously distributed only in one component of the fiber body. By means of this specific embodiment, it is possible, for example, to melt the sheath of a core-sheath continuous fiber in order to connect to further endless fibers without adversely affecting the dopant present in the core. Against this background, it is conceivable that side-by-side bicomponent endless fibers are also used. It is also conceivable to use Iceland-in-the-Sea bicomponent fiber end-products.
Der Dotierstoff könnte in einer Konzentration von mindestens 200 ppm im Vliesstoff vorliegen. Überraschenderweise hat sich gezeigt, dass bereits eine derart geringe Konzentration des Dotierstoffes eine antimikrobielle Wirkung gegen Viren, Sporen oder Bakterien entfalten kann.The dopant could be present in a concentration of at least 200 ppm in the nonwoven fabric. Surprisingly, it has been found that even such a low concentration of the dopant can develop an antimicrobial action against viruses, spores or bacteria.
Der Dotierstoff könnte in einer Konzentration von höchstens 500 ppm im Vliesstoff vorliegen. Die Wahl dieser Konzentration hat sich als vorteilhaft erwiesen, um einem eingefärbten Vliesstoff eine dauerhafte Reaktivität zu verleihen. Durch die Einfärbung wird der Dotierstoff zwar abgeschirmt, durch die genannte Konzentration kann er jedoch seine Wirkung noch in ausreichendem Maße entfalten.The dopant could be present in a concentration of at most 500 ppm in the nonwoven fabric. The choice of this concentration has been found to be advantageous to give a dyed nonwoven durable reactivity. Although the doping is shielded by the coloring, it can still exert its effect to a sufficient extent by the said concentration.
Die Bikomponentenfaser könnte eine Komponente aus Polyamid oder Polyethylen und eine Komponente aus Polyethylenterephtalat oder Polyester aufweisen, Durch diese konkrete Ausgestaltung ist es problemlos möglich, die Bikomponentenfaser durch Wasserstrahlen in Elementarfasern aufzuspalten.The bicomponent fiber could be a component of polyamide or polyethylene and a component of polyethylene terephthalate or polyester By this specific embodiment, it is easily possible to split the bicomponent fiber by water jets in elementary fibers.
Vor diesem Hintergrund könnte die Bikomponentenfaser 30% Polyamid oder Polymethylen aufweisen. Der Anteil an Polyethylentenephtalat oder Polyester beträgt im Wesentlichen 70 %.Against this background, the bicomponent fiber could comprise 30% polyamide or polymethylene. The proportion of polyethylene terephthalate or polyester is essentially 70%.
Der Dotierstoff könnte in der Komponente des Faserkörpers homogen verteilt sein, die Polyethylenterephtalat oder Polyester aufweist. Polyethylenterephtalat und Polyester haben sich als besonders geeignete Medien zur Aufnahme des Dotierstoffes erwiesen. Aufgrund des höheren Massenanteils der Komponente, die Polyethylenterephtalat oder Polyester aufweist, kann eine effektivere Volumenverteilung des Dotierstoffs im Vliesstoff erzielt werden.The dopant could be homogeneously distributed in the component of the fiber body comprising polyethylene terephthalate or polyester. Polyethylene terephthalate and polyesters have proven to be particularly suitable media for receiving the dopant. Due to the higher mass fraction of the component comprising polyethylene terephthalate or polyester, a more effective volume distribution of the dopant in the nonwoven fabric can be achieved.
Der Dotierstoff könnte als Element einer Nebengruppe, insbesondere der Nebengruppe lb des Periodensystems der Elemente, ausgestaltet sein. Nebengruppenelemente zeichnen sich durch antimikrobielle Wirkung aus. Vor diesem Hintergrund ist denkbar, dass mehrere Nebengruppenelemente gemeinsam in dem Faserkörper vorliegen, um unterschiedlichen Bakterienarten selektiv zu begegnen. Es hat sich in Versuchsreihen gezeigt, dass sich in Bezug auf die antimikrobielle Wirksamkeit eine Rangfolge der verwendeten Stoffe ergibt. Diese lässt sich wie folgt darstellen. Silber ist der wirksamste Stoff, gefolgt von Quecksilber, Kupfer, Cadmium, Chrom, Blel, Kobalt, Gold, Zink, Eisen und schließlich Mangan. Das gleiche gilt für Salze und Komplexe der genannten Elemente bzw. Stoffe.The dopant could be configured as an element of a subgroup, in particular subgroup 1b of the Periodic Table of the Elements. Subgroup elements are characterized by antimicrobial activity. Against this background, it is conceivable that several subgroup elements are present together in the fiber body in order to selectively counteract different bacterial species. It has been shown in test series that there is a ranking of the substances used in terms of antimicrobial effectiveness. This can be represented as follows. Silver is the most effective substance, followed by mercury, copper, cadmium, chromium, blel, cobalt, gold, Zinc, iron and finally manganese. The same applies to salts and complexes of the named elements or substances.
Der Dotierstoff könnte vor diesem Hintergrund als Silber, Gold oder Kupfer ausgestaltet sein. Diese Elemente zeigen eine besonders zuverlässige antimikrobielle Wirkung und sind kommerziell problemlos als feine Partikel erhältlich.The dopant could be designed against this background as silver, gold or copper. These elements show a particularly reliable antimicrobial effect and are readily available commercially as fine particles.
Der Vliesstoff könnte ein Flächengewicht von mindestens 20 g/m2 aufweisen. Dieses Flächengewicht hat sich als besonders vorteilhaft erwiesen, um Wischtücher herzustellen.The nonwoven fabric could have a basis weight of at least 20 g / m 2 . This basis weight has proved to be particularly advantageous for producing wipes.
Der hier beschriebene Vliesstoff kann problemlos in Kontakt zur menschlichen Haut stehen. Vorteilhaft weist der hier beschriebene Vliesstoff eine derart geringe Konzentration eines Dotierstoffs auf, dass die menschliche Haut nicht gereizt wird. Insbesondere Neurodermitispatienten bedürfen eines schonenden Vliesstoffes, wie es hier beschrieben ist. Dennoch zeigen die Endlosfasem auch auf der Filamentoberfläche eine ausreichende Konzentration des Dotierstoffs, um Bakterien, Viren und Sporen abzutöten.The nonwoven fabric described here can easily be in contact with human skin. Advantageously, the nonwoven fabric described herein has such a low concentration of a dopant that the human skin is not irritated. In particular eczema patients require a gentle nonwoven fabric, as described here. Nevertheless, the continuous fibers also show a sufficient concentration of the dopant on the filament surface in order to kill bacteria, viruses and spores.
Es gibt nun verschiedene Möglichkeiten, die Lehre der vorliegenden Erfindung auf vorteilhafte Weise auszugestalten und weiterzubilden. Dazu ist einerseits auf die nachgeordneten Ansprüche, andererseits auf die nachfolgende Erläuterung bevorzugter Ausführungsbeispiele der erfindungsgemäßen Lehre anhand der Tabelle und der Zeichnung zu verweisen.There are now various possibilities for embodying and developing the teaching of the present invention in an advantageous manner. For this purpose, on the one hand to the subordinate claims, on the other hand, to refer to the following explanation of preferred embodiments of the teaching of the invention with reference to the table and the drawings.
In Verbindung mit der Erläuterung der bevorzugten Ausführungsbeispiele anhand der Tabelle und der Zeichnung werden auch im Allgemeinen bevorzugte Ausgestaltungen und Weiterbildungen der Lehre erläutert.In connection with the explanation of the preferred embodiments with reference to the table and the drawing also generally preferred embodiments and developments of the teaching are explained.
In der Zeichnung zeigen
- Fig. 1
- eine rastenelektronenmikroskobische Aufnahme eines Vliesstoffes, welcher PIE-Bikomponentenfasern mit antimikrobieller Ausrüstung umfasst, und
- Fig. 2
- eine rasterelektronenmikroskobische Aufnahme von PIE-Fasem, deren Polyethylenterephtalatkomponente mit Silber dotiert ist, wobei sich das Silber in hellen, weisslichen Punkte zeigt.
- Fig. 1
- a scanning electron micrograph of a nonwoven fabric comprising PIE bicomponent fibers with antimicrobial finish, and
- Fig. 2
- a scanning electron micrograph of PIE-Fasem whose polyethylene terephthalate component is doped with silver, wherein the silver shows in bright whitish dots.
In der Zeichnung zeigt
Die Tabelle zeigt die drei Ausführungsbeispiele 1 bis 3 des erfindungsgemäßen Vliesstoffes. Die Ausführungsbeispiele 1 bis 3 zeigen unterschiedliche Konzentrationen des Dotierstoffes in der Polyethylenterephtalatkomponente. Die Herstellung der Vliesstoffe (Ausführungsbeispiele 1 bis 3) erfolgte in Anlehnung an das in
Die Polyethylenterephtalatkomponente wurde bei jedem der Ausführungsbeispiele 1 bis 3 in folgender Weise hergestellt:The polyethylene terephthalate component was prepared in each of Embodiments 1 to 3 in the following manner.
Zur Herstellung des Ausführungsbeispiels 1 wurden 970 g Polyethylenterephtalat mit 30 g einer Master-Batch-Komponente gemischt, um eine 3%ige Konzentration an Master-Batch im Sinne der Tabelle zu erhalten . Dabei enthielt die Master-Batch-Komponente 99 % Polyethylenterephtalat und 1 % Silber. Analog wurden für das Ausführungsbeispiel zwei 960 g Polyethylenterephtalat mit 40 g der Master-Batch-Komponente gemischt. Für Ausführungsbeispiel drei wurden 950 g Polyethylenterephtalat mit 50 g der genannten Master-Batch-Komponente gemischt. Als Dotierstoff wurde Silber der Firma Silanotex GmbH, 80687 München, verwendet. Ganz konkret wurde als Master-Batch "Nano-Silver-Master-Batch" der genannten Firma in den genannten Mengen verwendet.To prepare Embodiment 1, 970 g of polyethylene terephthalate were mixed with 30 g of a master batch component to obtain a 3% concentration of master batch as shown in the table. The masterbatch component contained 99% polyethylene terephthalate and 1% silver. Similarly, for the embodiment, two 960 grams of polyethylene terephthalate were mixed with 40 grams of the master batch component. For embodiment three, 950 g of polyethylene terephthalate were mixed with 50 g of said master batch component. The dopant used was silver from Silanotex GmbH, 80687 Munich. In concrete terms, the master batch was "Nano-Silver-Master-Batch" of the named company in the mentioned quantities.
Die Vliesstoffe der Ausführungsbeispiele 1 bis 3 wurden auf ihre Weiterreißfestigkeit, ihre Reißfestigkeit, ihre Dehnbarkeit, ihre Einheitlichkeit, ihre Permeabilität, ihre Dicke, ihr Flächengewicht und ihren Schrumpf untersucht. Dabei steht "N" für Newton, "MD" für machine direction (Produktionsrichtung) und "CD" für cross direction. MD und CD bezeichnen dabei orthogonal zueinander stehende Belastungsrichtungen, nämlich in Produktionsrichtung und orthogonal hierzu.The nonwoven fabrics of Working Examples 1 to 3 were evaluated for their tear propagation resistance, tear resistance, extensibility, uniformity, permeability, thickness, basis weight and shrinkage. Where "N" stands for Newton, "MD" for machine direction (production direction) and "CD" for cross direction. Denote MD and CD while orthogonal to each other load directions, namely in the direction of production and orthogonal thereto.
Als Vergleichsprobe diente dabei ein Vliesstoff des Typs Evolon mit einem Flächengewicht von 130 g/m2. Das Vergleichsbeispiel ist aus Bikomponentenfasern gefertigt, welche 70 % Polyethylenterephtalat und 30 % Polyamid 6 aufweisen. Bei dem in den Ausführungsbeispielen 1 bis 3 verwendeten Polyamid handelt es sich ebenfalls um Polyamid 6.The comparative sample used was a nonwoven fabric of the type Evolon with a basis weight of 130 g / m 2 . The comparative example is made from bicomponent fibers comprising 70% polyethylene terephthalate and 30% polyamide 6. The polyamide used in the embodiments 1 to 3 is also polyamide 6.
Der Tabelle kann im Wesentlichen entnommen werden, dass die Dotierung der Ausführungsbeispiele 1 bis 3 mit Silber keine negativen Auswirkungen auf die mechanischen Eigenschaften der Ausführungsbeispiele im Vergleich zur Vergleichsprobe hat. Die Ausführungsbeispiele wurden bis auf die Dotierung analog zur Vergleichsprobe gefertigt, die im Handel unter der Produktbezeichnung "EVOLON 130 g/m2" bzw. "EVO 130" erhältlich ist.The table essentially states that the doping of embodiments 1 to 3 with silver has no negative effects on the mechanical properties of the exemplary embodiments in comparison with the comparative sample. The exemplary embodiments were manufactured analogously to the comparative sample except for the doping, which is commercially available under the product designation "EVOLON 130 g / m 2 " or "EVO 130".
Schließlich sei ausdrücklich darauf hingewiesen, dass die voranstehend beschriebenen Ausführungsbeispiele lediglich zur Erörterung der beanspruchten Lehre dienen, diese jedoch nicht auf diese Ausführungsbeispiele einschränken.
Claims (11)
- Use of a bonded fibrous nonwoven web fabric in a wiping cloth or for producing a wiping cloth, wherein the bonded fibrous nonwoven web fabric comprises bicomponent fibres having a fibre body including at least one dopant for antimicrobial performance, wherein the bicomponent fibres are constructed as continuous filament fibres, wherein the bicomponent fibres are splittable into elemental fibres, wherein a bicomponent fibre is constructed as a PIE fibre and wherein the bonded fibrous nonwoven web fabric is characterized by a coloration, characterized in that the bonded fibrous nonwoven web fabric is coloured such that the dopant is shielded by the coloration.
- Use according to Claim 1, characterized in that the elemental fibres have a fineness in the range from 0.05 to 1 dtex.
- Use according to Claim 1 or 2, characterized in that the dopant forms a homogeneous distribution in one component only of the fibre body.
- Use according to any of Claims 1 to 3, characterized in that the dopant is present in a concentration of at least 200 ppm.
- Use according to any of Claims 1 to 4, characterized in that the dopant is present in a concentration of at most 500 ppm.
- Use according to any one of Claims 1 to 5, characterized in that the bicomponent fibre has one component of polyamide or polyethylene and one component of polyethylene terephthalate or polyester.
- Use according to Claim 6, characterized in that the bicomponent fibre includes 30% of polyamide or polyethylene.
- Use according to Claim 6 or 7, characterized in that the dopant forms a homogeneous distribution in that component of the fibre body which includes polyethylene terephthalate or polyester.
- Use according to any one of Claims 1 to 8, characterized in that the dopant is embodied as an element of a transition group, in particular transition group I b.
- Use according to Claim 9, characterized in that the dopant is embodied as silver, gold or copper.
- Use according to any one of Claims 1 to 10, characterized by a basis weight of at least 20 g/m2.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES08005131T ES2365270T3 (en) | 2008-03-19 | 2008-03-19 | WASHING MOP WITH AN UNFABRICATED MATERIAL EQUIPPED WITH AN ANTIBACTERIAL PREPARATION. |
AT08005131T ATE512243T1 (en) | 2008-03-19 | 2008-03-19 | WIPE CLOTH WITH AN ANTIBACTERIAL FINISHED NON-WOVEN FABRIC |
EP08005131A EP2103724B1 (en) | 2008-03-19 | 2008-03-19 | Wiping cloth with an antibacterial non-woven fabric |
PCT/EP2009/001721 WO2009115217A1 (en) | 2008-03-19 | 2009-03-11 | Nonwoven fabric provided with antibacterial finishing and having conjugate fibers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08005131A EP2103724B1 (en) | 2008-03-19 | 2008-03-19 | Wiping cloth with an antibacterial non-woven fabric |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2103724A1 EP2103724A1 (en) | 2009-09-23 |
EP2103724B1 true EP2103724B1 (en) | 2011-06-08 |
Family
ID=39789533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08005131A Active EP2103724B1 (en) | 2008-03-19 | 2008-03-19 | Wiping cloth with an antibacterial non-woven fabric |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2103724B1 (en) |
AT (1) | ATE512243T1 (en) |
ES (1) | ES2365270T3 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140018758A1 (en) * | 2012-07-13 | 2014-01-16 | The Procter & Gamble Company | Stretchable laminates for absorbent articles and methods for making the same |
CN106319754A (en) * | 2016-09-08 | 2017-01-11 | 河南工程学院 | Functional antibacterial composite wool flocculus and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2749860B1 (en) | 1996-06-17 | 1998-08-28 | Freudenberg Spunweb Sa | NON WOVEN TABLECLOTH FORMED OF VERY THIN CONTINUOUS FILAMENTS |
US6723428B1 (en) * | 1999-05-27 | 2004-04-20 | Foss Manufacturing Co., Inc. | Anti-microbial fiber and fibrous products |
WO2007078203A1 (en) * | 2006-01-03 | 2007-07-12 | Norwex Holding As | Anti-bacterial micro-fibre and production thereof |
-
2008
- 2008-03-19 EP EP08005131A patent/EP2103724B1/en active Active
- 2008-03-19 AT AT08005131T patent/ATE512243T1/en active
- 2008-03-19 ES ES08005131T patent/ES2365270T3/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2365270T3 (en) | 2011-09-27 |
EP2103724A1 (en) | 2009-09-23 |
ATE512243T1 (en) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10002778B4 (en) | Use of a microfilament nonwoven fabric as a cleaning cloth | |
EP0885321B1 (en) | Melt-blown non woven fabric, process for producing same and the uses thereof | |
DE60016590T2 (en) | ANTIMICROBIAL CLOTH OF ULTRA MICROFIBERS | |
AT512143B1 (en) | Cellulose fibers with hydrophobic properties and high softness and the associated manufacturing process | |
DE2731291C2 (en) | Suede-like textile composite and process for its manufacture | |
DE602006000082T2 (en) | Fiber with antimicrobial composition | |
DE2841749A1 (en) | METHOD FOR DETECTING AN IMPREGNATING AGENT AND SUBSTANCES PROVIDED WITH A DETECTING AGENT | |
DE69931553T2 (en) | Antimicrobial molding and process for its preparation | |
EP3212825B1 (en) | Liquid-impregnated nonwoven fabric which contains zinc oxide-containing cellulose fibers | |
DE112020000414T5 (en) | Antibacterial spunlace nonwoven fabric and manufacturing process therefor | |
EP1383947B2 (en) | Bioactive fiber products | |
EP2103724B1 (en) | Wiping cloth with an antibacterial non-woven fabric | |
EP2731487B1 (en) | Flat wiping cloth having antimicrobial or antibacterial equipment | |
DE102015010966A1 (en) | cleaning cloth | |
WO2009115217A1 (en) | Nonwoven fabric provided with antibacterial finishing and having conjugate fibers | |
WO2020025440A1 (en) | Nonwoven material, use of the nonwoven material, and wiping cloth, drying cloth and face mask containing the nonwoven material | |
DE10248583A1 (en) | Textile treatment agents | |
EP3690136A1 (en) | Nonwoven fibrous material | |
EP3056604B1 (en) | Plaster, washing and/or polishing substrate consisting of textile and/or non-woven and/or spongy structures for cleaning surfaces of any type with antimicrobial properties | |
DE102015119949A1 (en) | Color-dispensing product, in particular for dyeing or refreshing dyeings in textile materials | |
EP1358383A2 (en) | Method for providing fibres or non-woven fabric with an anti-microbial finish | |
EP1775372A2 (en) | Textile material finished with cationic compound and its use | |
DE102008015053A1 (en) | Antibacterial textile with bicomponent fibers, e.g. for clothing, has fiber body incorporating at least one doping substance for antimicrobial effect | |
DE60219358T2 (en) | DIFFERENTIALLY INTERRUPTED NONWOVENS AS WIPE CLOTH | |
DE202008018271U1 (en) | Reinigungstextilie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
17P | Request for examination filed |
Effective date: 20100302 |
|
17Q | First examination report despatched |
Effective date: 20100422 |
|
AKX | Designation fees paid |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HALLER, JUDITH Inventor name: GROTEN ROBERT Inventor name: EISENHUT, ANDREAS Inventor name: SCHINDLER THOMAS |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502008003782 Country of ref document: DE Effective date: 20110721 |
|
RIN2 | Information on inventor provided after grant (corrected) |
Inventor name: SCHINDLER THOMAS Inventor name: HALLER, JUDITH Inventor name: GROTEN ROBERT Inventor name: EISENHUT, ANDREAS |
|
REG | Reference to a national code |
Ref country code: NO Ref legal event code: T2 Effective date: 20110608 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2365270 Country of ref document: ES Kind code of ref document: T3 Effective date: 20110927 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20110608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110909 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111010 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111008 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20120309 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502008003782 Country of ref document: DE Effective date: 20120309 |
|
BERE | Be: lapsed |
Owner name: CARL FREUDENBERG K.G. Effective date: 20120331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120331 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20120319 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120331 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120331 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120331 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120319 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110908 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110608 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 512243 Country of ref document: AT Kind code of ref document: T Effective date: 20130319 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120319 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080319 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130319 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NO Payment date: 20230322 Year of fee payment: 16 Ref country code: FR Payment date: 20230322 Year of fee payment: 16 Ref country code: FI Payment date: 20230322 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20230323 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230331 Year of fee payment: 16 Ref country code: ES Payment date: 20230403 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FI Payment date: 20240326 Year of fee payment: 17 |